✦ LIBER ✦

Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery

✍ Scribed by Elizabeth J Shpall; Richard Champlin; John A Glaspy

Book ID: 117816110
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 128 KB
Volume: 4
Category: Article
ISSN: 1083-8791
DOI: 10.1053/bbmt.1998.v4.pm9763111

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of peripheral blood progenitor ce

Effect of peripheral blood progenitor cell dose on hematopoietic recovery: identification of minimal progenitor cell requirements for rapid engraftment

✍ Miyamoto, T; Shinozuka, T; Maeda, H; Hirasawa, T; Muramatsu, T; Murakami, M; Mak 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 206 KB

Evaluation of hematopoietic progenitors

Evaluation of hematopoietic progenitors in hematopoietic progenitor cell transplants. CD34+ dose effect in marrow recovery. Retrospective analysis in 38 patients

✍ R. Gabús; A. Magariños; M. Zamora; E. De Lisa; A.I. Landoni; G. Martínez; C. Can 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 287 KB

Low cell concentration of cryopreserved

Low cell concentration of cryopreserved autologous CD34+ peripheral blood progenitor cells does not impair hematopoietic recovery after transplantation

✍ Tommaso Caravita; Antonio Bruno; Gaspare Adorno; Susanna Santinelli; Agostina Si 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Evaluation of an algorithm based on peri

Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresis

✍ François Lefrère; Sarah Zohar; Sandrine Beaudier; Françoise Audat; Jean-Antoine 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Targeted transduction of CD34+ hematopoi

Targeted transduction of CD34+ hematopoietic progenitor cells in nonpurified human mobilized peripheral blood mononuclear cells

✍ Min Liang; Nonia Pariente; Kouki Morizono; Irvin S. Y. Chen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 973 KB

## Abstract ## Background Conventional gene‐therapy applications of hematopoietic stem cells (HSCs) involve purification of CD34+ progenitor cells from the mobilized peripheral blood, __ex vivo__ transduction of the gene of interest into them, and reinfusion of the transduced CD34+ progenitor cell

Clinical Applications of CD34+ Periphera

Clinical Applications of CD34+ Peripheral Blood Progenitor Cells (PBPC)

✍ Wichard Vogel; Stefan Scheding; Lothar Kanz; Wolfram Brugger 📂 Article 📅 2000 🏛 AlphaMed Press 🌐 English ⚖ 65 KB